Literature DB >> 4042815

Six cases of central serous choroidopathy induced by systemic corticosteroid therapy.

T Harada, K Harada.   

Abstract

We report 6 cases of central serous choroidopathy (including pigment epithelial detachment in one case) which appeared in the course of systemic corticosteroid administration conducted to cure concurrent general diseases, and in one patient with a steroid-releasing pituitary adenoma. The majority of cases arose within about one month following the administration of more than 200 mg of prednisolon. It is postulated that corticosteroids operate as a kind of stress intervening in the hypophysis-adrenal system, leading eventually to the development of central serous choroidopathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042815     DOI: 10.1007/bf00164568

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  5 in total

1.  THE ETIOLOGICAL AGENT OF SEROUS CENTRAL CHORIORETINITIS.

Authors: 
Journal:  Ophthalmologica       Date:  1964       Impact factor: 3.250

2.  Central serous retinopathy.

Authors:  G BENNETT
Journal:  Br J Ophthalmol       Date:  1955-10       Impact factor: 4.638

Review 3.  [Edematous maculopathies].

Authors:  G Coscas
Journal:  Bull Soc Ophtalmol Fr       Date:  1972

4.  Macular lesions during systemic therapy with depot tetracosactrin.

Authors:  J Williamson; G Nuki
Journal:  Br J Ophthalmol       Date:  1970-06       Impact factor: 4.638

5.  Maculopathy a corticosteroid side-effect.

Authors:  I S Jain; K Singh
Journal:  J All India Ophthalmol Soc       Date:  1966-12
  5 in total
  9 in total

Review 1.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  The relation of somatotypes and stress response to central serous chorioretinopathy.

Authors:  Roy Schwartz; Assaf Rozenberg; Anat Loewenstein; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-05       Impact factor: 3.117

4.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

5.  Circadian disturbance and idiopathic central serous chorioretinopathy.

Authors:  Elodie Setrouk; Beatrice Hubault; Frédérique Vankemmel; Olivia Zambrowski; Pierre Nazeyrollas; Brigitte Delemer; Vincent Durlach; Alain Ducasse; Carl Arndt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-21       Impact factor: 3.117

6.  Choroidal and Retinal Abnormalities by Optical Coherence Tomography in Endogenous Cushing's Syndrome.

Authors:  Maria Fernanda Abalem; Marcio Carlos Machado; Helen Nazareth Veloso Dos Santos; Rafael Garcia; John Helal; Pedro Carlos Carricondo; Sérgio Luis Gianotti Pimentel; Mario Luiz Ribeiro Monteiro; Cynthia X Qian; Marcello Delano Bronstein; Maria Cândida Villares Barisson Fragoso
Journal:  Front Endocrinol (Lausanne)       Date:  2016-12-09       Impact factor: 5.555

7.  Central serous chorioretinopathy with and without steroids: A multicenter survey.

Authors:  Takashi Araki; Hiroto Ishikawa; Chiharu Iwahashi; Masanori Niki; Yoshinori Mitamura; Masahiko Sugimoto; Mineo Kondo; Takamasa Kinoshita; Tomo Nishi; Tetsuo Ueda; Aki Kato; Tsutomu Yasukawa; Yoshihiro Takamura; Fumi Gomi
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

8.  Effect of short-term meditation training in central serous chorioretinopathy.

Authors:  Grisilda Nongrem; Abhidnya Surve; Pradeep Venkatesh; Rajesh Sagar; Raj K Yadav; Rohan Chawla; Rajpal Vohra; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

Review 9.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.